This month’s focus on pharmaphorum is clinical trials, so who better to share their view on global clinical trials than Zheng Su, Editor-in-Chief of the Contemporary Clinical Trials journal.

Unfortunately, delays and bureaucratic hurdles have steadily eroded the pharmaceutical industry’s enthusiasm for recruiting UK patients for large-scale clinical trials. The 2023 report by Lord O ...

Non-muscle invasive bladder cancer (NMIBC) has a long history of intravesical therapies. Intravesical treatments range from Bacillus Calmette-Guerin (BCG ...

The Madison Group Managing Partner and Republican Strategist Robb Watters says there will not be Medicaid cuts. Former Aide to President Obama and Democratic Strategist Robert Fisk believes we'll ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Text-to-image AI art generators ...

Our center is leading or participating in several clinical trials for both relapsing remitting and primary progressive MS. Our team is particularly dedicated to finding better treatments for ...